Annual CFO
-$26.65 M
+$364.30 K+1.35%
March 31, 2023
Summary
- As of February 10, 2025, YS annual cash flow from operations is -$26.65 million, with the most recent change of +$364.30 thousand (+1.35%) on March 31, 2023.
- During the last 3 years, YS annual CFO has risen by +$9.75 million (+26.78%).
Performance
YS Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFO
-$20.15 M
NaN%
September 30, 2023
Summary
- As of February 10, 2025, YS quarterly cash flow from operations is -$20.15 million
- Over the past year, YS quarterly CFO has dropped by -$4.47 million (-28.54%).
Performance
YS Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFO
-$20.15 M
NaN%
September 30, 2023
Summary
- As of February 10, 2025, YS TTM cash flow from operations is -$20.15 million
- Over the past year, YS TTM CFO has dropped by -$4.47 million (-28.54%).
Performance
YS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
YS Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.4% | -28.5% | -28.5% |
| 3 y3 years | +26.8% | - | - |
| 5 y5 years | +26.8% | - | - |
YS Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +36.6% | +28.5% | at low | +28.5% | at low |
| 5 y | 5-year | at high | +36.6% | +28.5% | at low | +28.5% | at low |
| alltime | all time | at high | +36.6% | +28.5% | at low | +28.5% | at low |
YS Biopharma Co Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$20.15 M(+28.5%) | -$20.15 M(+28.5%) |
| Mar 2023 | -$26.65 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$15.68 M | -$15.68 M |
| Mar 2022 | -$27.02 M(-25.8%) | - | - |
| Mar 2021 | -$36.40 M | - | - |
FAQ
- What is YS Biopharma Co annual cash flow from operations?
- What is the all time high annual CFO for YS Biopharma Co?
- What is YS Biopharma Co annual CFO year-on-year change?
- What is YS Biopharma Co quarterly cash flow from operations?
- What is the all time high quarterly CFO for YS Biopharma Co?
- What is YS Biopharma Co quarterly CFO year-on-year change?
- What is YS Biopharma Co TTM cash flow from operations?
- What is the all time high TTM CFO for YS Biopharma Co?
- What is YS Biopharma Co TTM CFO year-on-year change?
What is YS Biopharma Co annual cash flow from operations?
The current annual CFO of YS is -$26.65 M
What is the all time high annual CFO for YS Biopharma Co?
YS Biopharma Co all-time high annual cash flow from operations is -$26.65 M
What is YS Biopharma Co annual CFO year-on-year change?
Over the past year, YS annual cash flow from operations has changed by +$364.30 K (+1.35%)
What is YS Biopharma Co quarterly cash flow from operations?
The current quarterly CFO of YS is -$20.15 M
What is the all time high quarterly CFO for YS Biopharma Co?
YS Biopharma Co all-time high quarterly cash flow from operations is -$15.68 M
What is YS Biopharma Co quarterly CFO year-on-year change?
Over the past year, YS quarterly cash flow from operations has changed by -$4.47 M (-28.54%)
What is YS Biopharma Co TTM cash flow from operations?
The current TTM CFO of YS is -$20.15 M
What is the all time high TTM CFO for YS Biopharma Co?
YS Biopharma Co all-time high TTM cash flow from operations is -$15.68 M
What is YS Biopharma Co TTM CFO year-on-year change?
Over the past year, YS TTM cash flow from operations has changed by -$4.47 M (-28.54%)